The team behind this new meta-analysis reviewed data from more than 24,000 patients with a mean age of nearly 65 years old. They identified several benefits to choosing intravascular imaging guidance during PCI over traditional angiography alone.

Researchers tracked years of data, noting that strokes and other neurological adverse events reduce a patient's odds of survival.  

Specialists from the fields of interventional cardiology and cardiac surgery collaborated to perform what is believed to be the first completely catheter-based Fontan procedure in U.S. history. The young patient's recovery was much easier than it would have been otherwise. 

In addition, higher doses of oral HRT may slightly increase a woman's risk of experiencing a heart attack or stroke. 

“Patients are in desperate need of an effective treatment, and we are doing everything we can to help find that treatment,” one scientist explained. “The greatest reward would be to see a safe and effective treatment for people who currently have very few options.”

XCath Robotics has received the FDA's breakthrough device designation for its Iris surgical robotic system. The device is used to perform remote robotic-assisted mechanical thrombectomy on patients with acute ischemic stroke.

Wearable trackers found that PE patients were more active if they underwent mechanical thrombectomy than if they were just put on anticoagulation therapy alone.

Medtronic has received CE mark approval for a major change to the labeling of its Endurant stent graft system. A warning that the device has not been evaluated for the treatment of ruptured abdominal aortic aneurysms is no longer required.